Annual ROE
-73.67%
+22.41%+23.32%
31 December 2023
Summary:
Lyra Therapeutics annual return on equity is currently -73.67%, with the most recent change of +22.41% (+23.32%) on 31 December 2023. During the last 3 years, it has fallen by -43.97% (-148.05%). LYRA annual ROE is now -657.26% below its all-time high of 13.22%, reached on 31 December 2019.LYRA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-161.20%
-28.04%-21.06%
30 September 2024
Summary:
Lyra Therapeutics quarterly return on equity is currently -161.20%, with the most recent change of -28.04% (-21.06%) on 30 September 2024. Over the past year, it has dropped by -88.18% (-120.76%). LYRA quarterly ROE is now -270.62% below its all-time high of 94.48%, reached on 30 September 2020.LYRA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.3% | -120.8% |
| 3 y3 years | -148.1% | -169.3% |
| 5 y5 years | -1408.5% | - |
LYRA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -148.1% | +23.3% | -169.3% | at low |
| 5 y | 5 years | -657.3% | +23.3% | -270.6% | at low |
| alltime | all time | -657.3% | +23.3% | -270.6% | at low |
Lyra Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -161.20%(+21.1%) |
| June 2024 | - | -133.16%(+60.8%) |
| Mar 2024 | - | -82.82%(+10.8%) |
| Dec 2023 | -73.67%(-23.3%) | -74.78%(+2.4%) |
| Sept 2023 | - | -73.02%(+7.9%) |
| June 2023 | - | -67.69%(-13.9%) |
| Mar 2023 | - | -78.60%(-1.2%) |
| Dec 2022 | -96.08% | -79.54%(-8.6%) |
| Sept 2022 | - | -87.06%(-4.9%) |
| June 2022 | - | -91.57%(-19.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -113.96%(+35.2%) |
| Dec 2021 | -79.98%(+169.3%) | -84.26%(+40.8%) |
| Sept 2021 | - | -59.85%(+30.3%) |
| June 2021 | - | -45.92%(+38.4%) |
| Mar 2021 | - | -33.18%(-56.7%) |
| Dec 2020 | -29.70%(-324.7%) | -76.66%(-181.1%) |
| Sept 2020 | - | 94.48%(+197.5%) |
| June 2020 | - | 31.76%(+134.4%) |
| Mar 2020 | - | 13.55%(+2.5%) |
| Dec 2019 | 13.22%(+134.8%) | 13.22% |
| Dec 2018 | 5.63% | - |
FAQ
- What is Lyra Therapeutics annual return on equity?
- What is the all time high annual ROE for Lyra Therapeutics?
- What is Lyra Therapeutics annual ROE year-on-year change?
- What is Lyra Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly ROE year-on-year change?
What is Lyra Therapeutics annual return on equity?
The current annual ROE of LYRA is -73.67%
What is the all time high annual ROE for Lyra Therapeutics?
Lyra Therapeutics all-time high annual return on equity is 13.22%
What is Lyra Therapeutics annual ROE year-on-year change?
Over the past year, LYRA annual return on equity has changed by +22.41% (+23.32%)
What is Lyra Therapeutics quarterly return on equity?
The current quarterly ROE of LYRA is -161.20%
What is the all time high quarterly ROE for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly return on equity is 94.48%
What is Lyra Therapeutics quarterly ROE year-on-year change?
Over the past year, LYRA quarterly return on equity has changed by -88.18% (-120.76%)